SCHEMBL155346

SCHEMBL155346

O=C(O)CCCN1C(=O)C=CC1=O

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 7/20 0.85
PTGS2 P35354 7/20 0.85
MGLL Q99685 7/20 0.62
FAAH O00519 4/20 0.62
HSP90AA1 P07900 1/20 0.60
TLR9 Q9NR96 1/20 0.60
ALDH1A1 P00352 1/20 0.60
LMNA P02545 1/20 0.60
TP53 P04637 1/20 0.60
MAPT P10636 1/20 0.60
PKM P14618 1/20 0.60
HPGD P15428 1/20 0.60
XBP1 P17861 1/20 0.60
MAPK1 P28482 1/20 0.60
HTT P42858 1/20 0.60
RECQL P46063 1/20 0.60
RAB9A P51151 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
NPSR1 Q6W5P4 1/20 0.60
GPR35 Q9HC97 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17764749 0.98 PTGS1 (0.81) PTGS1PTGS2MGLLFAAHHSP90AA1
SCHEMBL3049679 0.98 PTGS1 (0.81) PTGS1PTGS2MGLLFAAHHSP90AA1
SCHEMBL6473262 0.98 PTGS1 (0.81) PTGS1PTGS2MGLLFAAHHSP90AA1
Hydrochloric Acid SCHEMBL17924135 0.98 PTGS1 (0.81) PTGS1PTGS2MGLLFAAHHSP90AA1
SCHEMBL3047985 0.98 PTGS1 (0.81) PTGS1PTGS2MGLLFAAHHSP90AA1
SCHEMBL2722163 0.94 PTGS1 (0.96) PTGS1PTGS2MGLLFAAHHSP90AA1
SCHEMBL27802760 0.92 PTGS1 (0.73) PTGS1PTGS2MGLLFAAHHSP90AA1
Alcohol SCHEMBL29133178 0.92 PTGS1 (0.73) PTGS1PTGS2MGLLFAAHHSP90AA1
SCHEMBL24939859 0.92 PTGS1 (1.00) PTGS1PTGS2MGLLFAAHHSP90AA1
SCHEMBL6934781 0.92 PTGS1 (1.00) PTGS1PTGS2MGLLFAAHHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2083 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250276013-A1 Cells Modified by Conjugated N-Terminal Glycine and Uses Thereof WESTLAKE THERAPEUTICS (HANGZHOU) CO. LIMITED (CN) 2025-09-04 US claimed
US-20250241113-A1 FILM, OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE TCL TECHNOLOGY GROUP CORPORATION (CN) 2025-07-24 US claimed
WO-2025127865-A1 METHOD FOR MANUFACTURING PEROVSKITE NANOCRYSTALS BY USING COLD-INJECTION METHOD, AND PEROVSKITE LIGHT-EMITTING DEVICE COMPRISING PEROVSKITE NANOCRYSTALS MANUFACTURED THEREBY 서울대학교산학협력단 2025-06-19 WO claimed
CN-120005123-A Acrylic ester block copolymer resin, photoresist, and preparation method and application thereof 中国石油化工股份有限公司 2025-05-16 CN claimed
WO-2025087855-A1 VACCINATION AGAINST THE AMYLOID-BETA 40 PEPTIDE ARACLON BIOTECH, S.L. (ES) 2025-05-01 WO claimed
US-20250127028-A1 PEROVSKITE LIGHT-EMITTING LAYER AND DEVICE USING THE SAME SN DISPLAY CO LTD (KR) 2025-04-17 US claimed
CN-119771343-A Nano magnetic bead and preparation method and application thereof 苏州海狸生物医学工程有限公司 2025-04-08 CN claimed
CN-119715819-A Method for detecting blood concentration of NTCP long-acting inhibitor by mass spectrometry 前沿生物药业(南京)股份有限公司 2025-03-28 CN claimed
EP-4251210-B1 MULTI-SPECIFIC HUMAN ALBUMIN NANOPARTICLES DECORATED WITH ANTIBODY FRAGMENTS AND LOADED WITH CYTOTOXICS ANBITION S R L (IT) 2025-03-19 EP claimed
WO-2025051254-A1 CYSTEINE ENGINEERED ANTIBODY AND IMMUNOCONJUGATE 信达生物制药(苏州)有限公司 2025-03-13 WO claimed
WO-2007029980-A1 MAGNETIC NANOPARTICLE HAVING FLUORESCENT AND PREPARATION METHOD THEREOF AND USE THEREOF BITERIALS CO., LTD. (KR) 2007-03-15 WO claimed
EP-1689846-A2 METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES, AND METHODS OF MAKING SAID CONJUGATES Immunogen, Inc. (US) 2006-08-16 EP claimed
US-20050239688-A1 Method for the synthesis of anthracycline-peptide conjugates UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) 2005-10-27 US claimed
WO-2005037992-A2 METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES, AND METHODS OF MAKING SAID CONJUGATES IMMUNOGEN, INC. (US) 2005-04-28 WO claimed
EP-1525002-A1 METHOD FOR THE SYNTHESIS OF ANTHRACYCLINE-PEPTIDE CONJUGATES UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) 2005-04-27 EP claimed
US-20050003459-A1 Multi-purpose optical analysis disc for conducting assays and related methods for attaching capture agents VINDUR TECHNOLOGIES, INC. (NO) 2005-01-06 US claimed
WO-2004011033-A1 METHOD FOR THE SYNTHESIS OF ANTHRACYCLINE-PEPTIDE CONJUGATES UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) 2004-02-05 WO claimed
EP-0942932-A1 MULTIMERIC ERYTHROPOIETIN WITH INCREASED BIOLOGICAL ACTIVITY Beth Israel Deaconess Medical Center (US) 1999-09-22 EP claimed
WO-1999038891-A1 MULTIMERIC ERYTHROPOIETIN WITH ALTERED BIOLOGICAL ACTIVITY BETH ISRAEL DEACONESS MEDICAL CENTER (US) 1999-08-05 WO claimed
WO-1998023643-A1 MULTIMERIC ERYTHROPOIETIN WITH INCREASED BIOLOGICAL ACTIVITY BETH ISRAEL DEACONESS MEDICAL CENTER (US) 1998-06-04 WO claimed